查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲急性胰臟炎市场预测至 2030 年 - 区域分析 - 按产品、原因和最终用户
市场调查报告书
商品编码
1452553

南美洲和中美洲急性胰臟炎市场预测至 2030 年 - 区域分析 - 按产品、原因和最终用户

South & Central America Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User
出版日期: | 出版商: The Insight Partners | 英文 93 Pages | 订单完成后即时交付

价格

2022年，南美洲和中美洲急性胰臟炎市值为2.0904亿美元，预计2030年将达到3.3367亿美元；预计 2022 年至 2030 年CAGR为 6.0%。

急性胰臟炎研发活动和宣传项目数量激增推动南美洲和中美洲急性胰臟炎市场

全球正在进行广泛的研究，以调查急性胰臟炎的病因、进展和治疗。国家胰臟基金会 (NPF) 提供多项研究资助，每个计画价值约 5 万美元。迄今为止，NPF 已为 133 个突破性研究项目提供了超过 500 万美元的资金。授予为期一年的补助金，用于诊断和/或治疗胰臟炎、胰臟癌或小儿胰臟炎。

此外，国际上正在进行一些努力来定义急性胰臟炎的流行病学和病理生理学。美国国立卫生研究院 (NIH) 的国家糖尿病、消化和肾臟疾病研究所 (NIDDK) 于 2020 年组建了一个由 10 个临床中心和 1 个资料协调中心组成的协作网络，以解决有关急性胰臟炎的多个知识缺口。该联盟被称为急性胰臟炎联盟 (T1DAPC) 后的第 1 型糖尿病。因此，针对急性胰臟炎开发有效疗法（透过直接和间接手段）的研发活动和宣传计画预计将为南美洲和中美洲急性胰臟炎市场的公司带来丰硕成果。

南美洲和中美洲急性胰臟炎市场概述

南美洲和中美洲急性胰臟炎市场分为巴西、阿根廷以及南美洲和中美洲其他地区。该地区老年人口的增加和急性胰臟炎病例的增加正在推动该地区南美洲和中美洲急性胰臟炎市场的成长。急性胰臟炎是一种危及生命的疾病，尤其是由于合併症和身体系统受损而导致的老年族群。据巴西卫生部称，到 2030 年，巴西老年人口预计将在全球排名第五。世界卫生组织预计，2050年，我国老年人口将增加300%以上，总人口将成长30%。根据泛美卫生组织（PAHO）统计，2022年，巴西60岁以上人口将超过3,000万，占总人口的30%。预计到2050年，60岁以上的人口将达到约5,000万，占巴西总人口的24%。除了老化之外，饮酒也会导致急性胰臟炎。根据《自然》杂誌发表的一篇文章，巴西饮酒者总数的85.2%是重度饮酒者。因此，巴西酒精消费的增加也推动了南美洲和中美洲急性胰臟炎市场的成长。

南美洲及中美洲急性胰臟炎市场收入及 2030 年预测（百万美元）

南美洲和中美洲急性胰臟炎市场细分

南美洲和中美洲急性胰臟炎市场按产品、原因、最终用户和国家进行细分。

根据产品，南美洲和中美洲急性胰臟炎市场分为药物、诊断等。 2022年，诊断细分市场占据最大市场份额。

根据病因，南美洲和中美洲急性胰臟炎市场分为胆结石、酗酒、遗传性疾病、感染等。 2022 年，胆结石细分市场占据最大的市场份额。

根据最终用户，南美洲和中美洲急性胰臟炎市场分为医院、诊断实验室、门诊手术中心等。 2022 年，医院细分市场占据最大市场份额。

根据国家/地区，南美洲和中美洲急性胰臟炎市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，南美洲和中美洲其他地区主导了南美洲和中美洲急性胰臟炎市场份额。

Abbott Laboratories、Baxter International Inc、Boston Scientific Corp、Fresenius Kabi AG、GE HealthCare Technologies Inc、Koninklijke Philips NV、Medtronic Plc 和 Samsung Healthcare 是南美洲和中美洲急性胰臟炎市场的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解
  • 南美洲和中美洲急性胰臟炎市场（按国家）

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲急性胰臟炎市场格局

  • 概述

第 5 章：南美洲和中美洲急性胰臟炎市场 - 主要产业动态

  • 主要市场驱动因素
    • 急性胰臟炎导致胰臟癌病例增加
    • 急性胰臟炎后糖尿病发生率上升
  • 主要市场限制
    • 胰臟炎和胰臟癌治疗的副作用
  • 主要市场机会
    • 急性胰臟炎的研发活动和宣传项目数量激增
  • 未来的趋势
    • 特异性急性胰臟炎治疗的进展
  • 影响分析：

第 6 章： 急性胰臟炎市场 - 南美洲和中美洲市场分析

  • 南美洲和中美洲急性胰臟炎市场收入，2022 - 2030

第 7 章：南美洲和中美洲急性胰臟炎市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年和 2030 年南美洲和中美洲急性胰臟炎市场收入份额（按产品划分）（%）
  • 药物
  • 诊断
  • 其他的

第 8 章：南美洲和中美洲急性胰臟炎市场 - 2030 年收入和预测 - 按原因

  • 概述
  • 2022 年和 2030 年南美洲和中美洲急性胰臟炎市场收入份额（按原因划分）
  • 胆结石
  • 酗酒
  • 遗传性疾病
  • 感染
  • 其他的

第 9 章：南美洲和中美洲急性胰臟炎市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 南美洲和中美洲急性胰臟炎市场收入份额（按最终用户），2022 年和 2030 年（%）
  • 医院
  • 诊断实验室
  • 门诊手术中心
  • 其他的

第 10 章：南美洲和中美洲急性胰臟炎市场 - 国家分析

  • 概述
      • 南美洲和中美洲急性胰臟炎市场（按国家）
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地区

第 11 章：南美洲和中美洲急性胰臟炎市场-产业格局

  • 概述
  • 南美洲和中美洲急性胰臟炎市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • Abbott Laboratories
  • GE HealthCare Technologies Inc
  • Samsung Healthcare
  • Koninklijke Philips NV
  • Baxter International Inc
  • Medtronic Plc
  • Boston Scientific Corp
  • Fresenius Kabi AG

第 13 章：附录

Product Code: BMIRE00029244

The South & Central America acute pancreatitis market was valued at US$ 209.04 million in 2022 and is expected to reach US$ 333.67 million by 2030; it is estimated to grow at a CAGR of 6.0% from 2022 to 2030.

Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis Fuels the South & Central America Acute Pancreatitis Market

Extensive research studies are being conducted globally to investigate the etiology, progress, and treatment of acute pancreatitis. The National Pancreas Foundation (NPF) provides multiple research grants worth ~US$ 50,000 per project. To date, the NPF has provided more than US$ 5 million for 133 ground-breaking research projects. A grant is awarded for a period of a year to diagnose and/or treat pancreatitis, pancreatic cancer, or pediatric pancreatitis.

Further, several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. The National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), formed a collaborative network of 10 clinical centers and 1 data coordination center in 2020 to address several knowledge gaps regarding acute pancreatitis. The consortium is referred to as Type 1 Diabetes after Acute Pancreatitis Consortium (T1DAPC). Thus, R&D activities and awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to be highly fruitful for companies in the South & Central America acute pancreatitis market.

South & Central America Acute Pancreatitis Market Overview

The South & Central America acute pancreatitis market is segmented into Brazil, Argentina, and the Rest of South & Central America. Increasing in geriatric population in the region and increase in cases of acute pancreatitis is fueling the growth of the South & Central America acute pancreatitis market in the region. Acute pancreatitis is a life-threatening disease, especially in the geriatric population due to co-morbidities and compromised body systems. As per Brazil's Ministry of Health, by 2030, Brazil is anticipated to rank fifth in terms of geriatric population worldwide. The WHO estimated that the elderly population will have increased by more than 300% and the overall population will grow by 30% by 2050 in the country. According to Pan American Health Organization (PAHO), in 2022, Brazil had more than 30 million people aged above 60, which represents 30% of the total population. The number of people aged above 60 is expected to reach ~50 million, which is expected to represent 24% of the total population of Brazil by 2050. Apart from aging, alcohol consumption can also cause acute pancreatitis. According to an article published in Nature, 85.2% of the total alcohol drinkers were heavy drinkers in Brazil. Thus, the increase in alcohol consumption in Brazil is also fueling the growth of the South & Central America acute pancreatitis market.

South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

South & Central America Acute Pancreatitis Market Segmentation

The South & Central America acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the South & Central America acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on causes, the South & Central America acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the South & Central America acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South & Central America acute pancreatitis market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America acute pancreatitis market share in 2022.

Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the South & Central America acute pancreatitis market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 South & Central America Acute Pancreatitis Market, by Country (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Acute Pancreatitis Market Landscape

  • 4.1 Overview

5. South & Central America Acute Pancreatitis Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
    • 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
  • 5.2 Key Market Restraints
    • 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
  • 5.3 Key Market Opportunities
    • 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
  • 5.4 Future Trends
    • 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
  • 5.5 Impact Analysis:

6. Acute Pancreatitis Market - South & Central America Market Analysis

  • 6.1 South & Central America Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

  • 7.1 Overview
  • 7.2 South & Central America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
  • 7.3 Medications
    • 7.3.1 Overview
    • 7.3.2 Medications: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 South & Central America Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
  • 7.4 Diagnosis
    • 7.4.1 Overview
    • 7.4.2 Diagnosis: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 South & Central America Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

  • 8.1 Overview
  • 8.2 South & Central America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
  • 8.3 Gallstones
    • 8.3.1 Overview
    • 8.3.2 Gallstones: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Alcoholism
    • 8.4.1 Overview
    • 8.4.2 Alcoholism: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genetic Disorders
    • 8.5.1 Overview
    • 8.5.2 Genetic Disorders: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Infections
    • 8.6.1 Overview
    • 8.6.2 Infections: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 South & Central America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Ambulatory Surgical Centers
    • 9.5.1 Overview
    • 9.5.2 Ambulatory Surgical Centers: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Acute Pancreatitis Market - Country Analysis

  • 10.1 Overview
      • 10.1.1.1 South & Central America Acute Pancreatitis Market, by Country
      • 10.1.1.2 Brazil
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Brazil: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 Brazil: South & Central America Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.2.3.1 Brazil: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.2.3.2 Brazil: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Brazil: South & Central America Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Brazil: South & Central America Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 Argentina
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Argentina: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 Argentina: South & Central America Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.3.3.1 Argentina: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.3.3.2 Argentina: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Argentina: South & Central America Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.3.5 Argentina: South & Central America Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.4 Rest of South & Central America
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.4.3.1 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.4.3.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.4.5 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)

11. South & Central America Acute Pancreatitis Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the South & Central America Acute Pancreatitis Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 GE HealthCare Technologies Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Samsung Healthcare
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Koninklijke Philips NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Baxter International Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Medtronic Plc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Boston Scientific Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Fresenius Kabi AG
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. South & Central America Acute Pancreatitis Market Segmentation
  • Table 2. South & Central America Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. South & Central America Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil: South & Central America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Brazil: South & Central America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Brazil: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Brazil: South & Central America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Brazil: South & Central America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Argentina: South & Central America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Argentina: South & Central America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Argentina: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Argentina: South & Central America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Argentina: South & Central America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Recent Inorganic Growth Strategies in the South & Central America Acute Pancreatitis Market
  • Table 20. Recent Organic Growth Strategies in the South & Central America Acute Pancreatitis Market
  • Table 21. Glossary of Terms, South & Central America Acute Pancreatitis Market

List Of Figures

  • Figure 1. South & Central America Acute Pancreatitis Market Segmentation, By Country
  • Figure 2. South & Central America Acute Pancreatitis Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. South & Central America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
  • Figure 6. Medications: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Diagnosis: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. South & Central America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
  • Figure 10. Gallstones: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Alcoholism: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Genetic Disorders: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Infections: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. South & Central America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 16. Hospitals: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Diagnostic Laboratories: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Ambulatory Surgical Centers: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. South & Central America Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 21. South & Central America Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
  • Figure 22. Brazil: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. Argentina: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Rest of South & Central America: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Growth Strategies in the South & Central America Acute Pancreatitis Market